Samick THK삼익THK

Samick THK is loss-making on a trailing basis, with revenue shrinking and the share price down sharply over the past year.

Samick THK reported trailing revenue of ₩253B for the twelve months to H1 2026, with an operating loss of ₩24.5B and a net loss of ₩15.3B. Its 2025 full-year results were weaker still, with a net loss of ₩45B on revenue of ₩222B. At a close of ₩7,190 the market cap is about ₩149B, and the shares are down 44.7% over one year.

What stands out

• Revenue fell 27% in 2025 to ₩222B, after declines in 2024 and 2023, so the top line has been shrinking for three years.
• Operating margin is -9.7% on a trailing basis, compared with small positive margins in 2021 to 2024.
• Borrowings of ₩162B are high relative to cash of ₩29B, and liabilities are 159.4% of equity.
• Trailing free cash flow is positive at ₩23.6B despite the accounting losses.
• Foreign ownership eased slightly from 37.7% to 37.3% over about 60 days, and the largest shareholder filed several holding-change reports during 2026.

What to watch

• The next quarterly or annual results, to see whether operating losses narrow from the trailing -9.7% margin.
• Progress on debt levels relative to cash, given the high liabilities-to-equity ratio.
• Further filings on largest shareholder holding changes and insider or executive share plans, which were filed in October 2026.